Deep multi-view contrastive learning for cancer subtype identification
Briefings in Bioinformatics · 20.09.2023 · 24 (5)
DOI: 10.1093/bib/bbad282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 03.08.2023. Verfasst von Wenlan Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Information Science and Engineering, Shandong Normal University, Jinan, 250358, China. Hauptthemen laut MEDLINE: Liver Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer heterogeneity has posed great challenges in exploring precise therapeutic strategies for cancer treatment. The identification of cancer subtypes aims to detect patients with distinct molecular profiles and thus could provide new clues on effective clinical therapies. While great efforts have been made, it remains challenging to develop powerful computational methods that can efficiently integrate multi-omics datasets for the task. In this paper, we propose a novel self-supervised learning model called Deep Multi-view Contrastive Learning (DMCL) for cancer subtype identification. Specifically, by incorporating the reconstruction loss, contrastive loss and clustering loss into a unified framework, our model simultaneously encodes the sample discriminative information into the extracted feature representations and well preserves the sample cluster structures in the embedded space. Moreover, DMCL is an end-to-end framework where the cancer subtypes could be directly obtained from the model outputs. We compare DMCL with eight alternatives ranging from classic cancer subtype identification methods to recently developed state-of-the-art systems on 10 widely used cancer multi-omics datasets as well as an integrated dataset, and the experimental results validate the superior performance of our method. We further conduct a case study on liver cancer and the analysis results indicate that different subtypes might have different responses to the selected chemotherapeutic drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Information Science and Engineering, Shandong Normal University, Jinan, 250358, China.
Förderung
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Chen, W., Wang, H., & Liang, C. (2023). Deep multi-view contrastive learning for cancer subtype identification. Briefings in Bioinformatics, 24(5). https://doi.org/10.1093/bib/bbad282
Vancouver
Chen W, Wang H, Liang C. Deep multi-view contrastive learning for cancer subtype identification. Briefings in Bioinformatics. 2023;24(5). doi:10.1093/bib/bbad282
BibTeX
@article{Chen2023,
author = {Chen, Wenlan and Wang, Hong and Liang, Cheng},
title = {Deep multi-view contrastive learning for cancer subtype identification},
journal = {Briefings in Bioinformatics},
year = {2023},
volume = {24},
number = {5},
doi = {10.1093/bib/bbad282}
}
EUVIMED